Showing solid expertise in general seed investments and pre-seed funding rounds, Penningtons Manches Cooper LLP regularly acts for investors, venture capital-backed companies, and international corporates, particularly within the life sciences and tech spaces. Based out of Oxford, James Went leads the venture capital side, covering funding rounds and exit transactions, Will Axtell represents entrepreneurs and growth businesses, and Kathy Potter is also highlighted as key. Matthew Martin, who acts as the global head of corporate, is a further notable contact.
Legal 500 Editorial commentary
Key clients
- Open Cosmos Ltd.
- Oxford Flow Limited
- Ingenox Therapeutics Limited
- Pictura Bio Ltd
- Matta Labs Limited
- Naturbeads Limited
- Seloxium Limited
- Mint Neurotechnologies
- MitoRx Therapeutics
- Oxford Vacmedix Limited
Work highlights
Advised Oxford Flow Limited, a designer and manufacturer of groundbreaking pressure valve technology, on its $25m Series C funding round led by bp Ventures and Energy Impact Partners
Acted for Matta Labs on its spin-out from the University of Cambridge, including licensing of IP, and pre-seed funding round led by Giant Ventures with Unruly Capital, Boost VC, Giant Ventures and Skydeck
Advised Mint Neurotechnologies on its £1m seed funding round led by Empirical Ventures with additional investment from Parkwalk Advisors, Imperial College London, Plug & Play, Excellis Holding, and several prominent angel investors
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Matthew Martin; James Went
Other key lawyers
Will Axtell; Kathy Potter; Adam Carling; Dominique Sabatini; Anoushka Gangji